IL15 and central nervous system cancer: IL13Rα2 CAR T cells engineered to additionally express IL-15 displayed greater anti-glioma activity and improved persistence and significantly prolonged survival of mice than control IL13Rα2 CAR T cells in orthotopic glioma xenograft models (Krenciute et al., 2017).